RE:RE:RE:RE:Not Impressed.....Do what you must. You obviously drink whatever kool-aid you are fed. Paul needs to answer the hard questions. Something cleary went offside. A few weeks back he was talking about 20,000 manufactured units a month, $12 000 US a unit sales price and demand exceeded supply. And November sales. Now we hear nothing. If you feed the masses this data you have to be accountable for it. The November sales may come but to not address it and the other data points I noted above is a Big concern to me. I am glad I derisked my investment in KNR. I already redeployed the cash and have done very well. I will have to retain my current KNR shares as selling them at these levels is silly. You obviously don't want to see reality. One day you may learn. LTD1
BCdude wrote: LOL He answerd all the questions he COULD answer, and stated very clearly that he would not answer the ones you want answered until there's material news to report.
My friend, this stock doesn't seem to be for you.
I'm afraid I just can't handle the shrillness of your commentary any more. No hard feelings, but you are henceforth going on ignore. Best of luck with your other investments. I know you've said it's been a good year for you, so iyou probably don't even need KNR.
LivingTheDream1 wrote: Wrong.....he left a lot of questions unanswered.
BCdude wrote: He specifically stated he doesn't look at day-to-day share price fluctuations, which is the right way to act. He's building a business, and if the "lack of progress" to date or continued uncertainties are not to your liking, then you should not invest in the company.
You've stated before that you're in this for a short-term gain, not a long-term hold; I think he provided you with an answer today.
LivingTheDream1 wrote: Here we are in the midst of the worst pandemic in a century and you have developed a device called BioCloud that you had tested to confirm the lower sensitivity limits for Covid and now you keep reiterating over and over again that the device is going to be able to address many different viruses now and for the next 10 years. Really? It is evident now that the market truely sold off for a reason. If BioCloud is as effective and in demand as you inferred for the past few months you truely would have sales by now. To hear the patent still has not been filed is another red herring? Why was this not addressed earlier? What is the real scoop? You need to be more open to shareholders. Yes we understand there is an underlying business that Kontrol runs but addressing covid is why the share price ran up to where it did. It is understandable why the share price dropped back to where it is now. This also explains why there has been no huge media blitz after the recent press releases. Disappointing.......